Doramectin — a potent novel endectocide

A. C. Goudie, N. A. Evans, K.A.F. Gration, +10

Veterinary Parasitology

Molecular PharmacologyMedicinal ChemistryPotent Novel EndectocideMedicinePharmacology +2

The metabolism and kinetics of doxazosin in man, mouse, rat and dog.

B. Kaye, N.J. Cussans, J. K. Faulkner, +2

British Journal of Clinical Pharmacology

Animal PhysiologyEnergy MetabolismOral BioavailabilityPharmacological StudyBiochemistry +13

Effect of formulation on the pharmacokinetics and efficacy of doramectin

S.R. Wicks, B. Kaye, Anthony J. Weatherley, +4

Veterinary Parasitology

Pharmaceutical SciencePharmacological StudyMedicineClinical PharmacologyPharmacotherapy +2

A species difference in the presystemic metabolism of carbazeran in dog and man

B. Kaye, J. L. Offerman, John L. Reid, +2

Xenobiotica

Oxidative metabolism of carbazeran<i>in vitro</i>by liver cytosol of baboon and man

B. Kaye, David J. Rance, Lyn Waring

Xenobiotica

The sensitive determination of abanoquil in blood by high-performance liquid chromatography/atmospheric pressure ionization mass spectrometry

B. Kaye, Mellissa Clark, N. J. CUSSANS, +2

Journal of Mass Spectrometry

Multiple Reaction MonitoringGas ChromatographyDrug PurityBioanalysisToxicology +15

Comparison of the serum pharmacokinetics of a long acting and a conventional oxytetracycline injection

L. A. Davey, M.T. Ferber, B. Kaye

Veterinary Record

Animal PhysiologyLong Acting FormulationAnimal ScienceBioanalysisPharmacology +13

The metabolism of oxamniquine—a new schistosomicide

B. Kaye, N. M. Woolhouse

Annals of Tropical Medicine and Parasitology

Bioorganic ChemistryAntiparasitic AgentSecondary MetaboliteRedox BiologyOxidative Stress +18

Formation and pharmacokinetics of the active drug candoxatrilat in mouse, rat, rabbit, dog and man following administration of the prodrug candoxatril

B. Kaye, Chris Brearley, N. J. CUSSANS, +3

Xenobiotica

PharmacotherapyProdrug CandoxatrilExperimental PharmacologyTranslational PharmacologyMolecular Pharmacology +14

Measurement of the class III antidysrhythmic drug, UK-68,798, in plasma by radioimmunoassay

Don K. Walker, G. Wynne Aherne, John Arrowsmith, +5

Journal of Pharmaceutical and Biomedical Analysis

Pharmaceutical ScienceMedicineImmunologyLaboratory MedicinePharmacotherapy +4